A phase II trial of neoadjuvant gemcitabine/nab-paclitaxel and SBRT for potentially resectable pancreas cancer: An evaluation of acute toxicity.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Palta, M; Czito, BG; Duffy, E; Malicki, M; Niedzwiecki, D; Abbruzzese, JL; Uronis, HE; Blobe, GC; Blazer, DG; Willett, C

Published Date

  • May 20, 2018

Published In

Volume / Issue

  • 36 / 15_suppl

Start / End Page

  • 4121 - 4121

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2018.36.15_suppl.4121